Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Biosynex

ALBIO
Current price
2.93 EUR +0.21 EUR (+7.73%)
Last closed 2.76 EUR
ISIN FR0011005933
Sector Healthcare
Industry Medical Devices
Exchange Euronext Paris
Capitalization 33 419 887 EUR
Yield for 12 month -63.93 %
1Y
3Y
5Y
10Y
15Y
ALBIO
21.11.2021 - 28.11.2021

Biosynex SA designs, manufactures, and distributes rapid diagnostic tests in France and internationally. The company offers medical devices for in vitro diagnosis in the form of rapid diagnostic tests, immunoblots, molecular biology, and point of care products for screening, diagnosis, and prevention in the areas of bacteriology, parasitology, mycology, virology, biochemistry and oncology, and women's health, as well as COVID-19 tests and instruments. It also provides self-tests; self-measurement products, including thermometers, oxymeters, and blood pressure monitors; and oral care and medical aid products. The company provides its products to biology and medical analysis laboratories, hospitals, pharmacies, hyper and supermarkets, etc. It also exports its products internationally. The company was founded in 1993 and is based in Illkirch-Graffenstaden, France. Address: 22 Boulevard SEbastien Brant, Illkirch-Graffenstaden, France, 67400

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

11.86 EUR

P/E ratio

Dividend Yield

Current Year

+93 312 051 EUR

Last Year

+197 292 839 EUR

Current Quarter

+53 892 934 EUR

Last Quarter

+50 505 808 EUR

Current Year

+49 308 521 EUR

Last Year

+64 752 136 EUR

Current Quarter

-10 638 084 EUR

Last Quarter

+25 753 195 EUR

Key Figures ALBIO

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -29 929 144 EUR
Operating Margin TTM -36.42 %
PE Ratio
Return On Assets TTM -9 %
PEG Ratio
Return On Equity TTM -25.5 %
Wall Street Target Price 11.86 EUR
Revenue TTM 93 312 052 EUR
Book Value 11.61 EUR
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -7.4 %
Dividend Yield
Gross Profit TTM 207 155 572 EUR
Earnings per share -3.47 EUR
Diluted Eps TTM -3.47 EUR
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY -56.6 %
Profit Margin -39.74 %

Dividend Analytics ALBIO

Dividend growth over 5 years

Continuous growth

1 year

Payout Ratio 5 years average

50 %

Dividend History ALBIO

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date 16.05.2022
Forward Annual Dividend Yield
Last Split Factor 697:694
Payout Ratio
Last Split Date 05.07.2017
Dividend Date

Stock Valuation ALBIO

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 0.7864
Price Sales TTM 0.3582
Enterprise Value EBITDA 0.6306
Price Book MRQ 0.2877

Financials ALBIO

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators ALBIO

For 52 weeks

2.66 EUR 9 EUR
50 Day MA 4 EUR
Shares Short Prior Month
200 Day MA 4.52 EUR
Short Ratio
Shares Short
Short Percent